ZIM

On December 16, 2025, the Group reached an agreement with the Issuer regarding the composition of the Issuer's Board of Directors ahead of ZIM's upcoming Annual and Extraordinary General Meeting of Shareholders scheduled to be held on December 26, 2025 (the "Annual Meeting"). Pursuant to the agreement, the Group agreed to withdraw its proxy contest, and ZIM's Board of Directors has approved a unified slate of ten director nominees to be presented to the shareholders at the Annual Meeting. The slate includes each of the Issuer's incumbent directors, as well as Ron Hadassi and Ran Gritzerstein, who will be recommended by the Board for election. In addition, Dr. Keren Bar-Hava (CPA) withdrew her candidacy for election as a director and has been appointed as an observer to the Board. The Group has also withdrawn its previously issued position statement. Each member of the Group publicly expressed full confidence in ZIM's Board of Directors, strongly supported the Board's ongoing strategic review, and endorsed the election of all ten director nominees recommended by the Board. Each member of the Group supported and was in favor of the Issuer's slate at the Annual Meeting and encouraged all ZIM shareholders to vote in favor of all the nominees.

On December 16, 2025, the Group reached an agreement with the Issuer regarding the composition of the Issuer's Board of Directors ahead of ZIM's upcoming Annual and Extraordinary General Meeting of Shareholders scheduled to be held on December 26, 2025 (the "Annual Meeting"). Pursuant to the agreement, the Group agreed to withdraw its proxy contest, and ZIM's Board of Directors has approved a unified slate of ten director nominees to be presented to the shareholders at the Annual Meeting. The slate includes each of the Issuer's incumbent directors, as well as Ron Hadassi and Ran Gritzerstein, who will be recommended by the Board for election. In addition, Dr. Keren Bar-Hava (CPA) withdrew her candidacy for election as a director and has been appointed as an observer to the Board. The Group has also withdrawn its previously issued position statement. Each member of the Group publicly expressed full confidence in ZIM's Board of Directors, strongly supported the Board's ongoing strategic review, and endorsed the election of all ten director nominees recommended by the Board. Each member of the Group supported and was in favor of the Issuer's slate at the Annual Meeting and encouraged all ZIM shareholders to vote in favor of all the nominees.

On December 16, 2025, the Group reached an agreement with the Issuer regarding the composition of the Issuer's Board of Directors ahead of ZIM's upcoming Annual and Extraordinary General Meeting of Shareholders scheduled to be held on December 26, 2025 (the "Annual Meeting"). Pursuant to the agreement, the Group agreed to withdraw its proxy contest, and ZIM's Board of Directors has approved a unified slate of ten director nominees to be presented to the shareholders at the Annual Meeting. The slate includes each of the Issuer's incumbent directors, as well as Ron Hadassi and Ran Gritzerstein, who will be recommended by the Board for election. In addition, Dr. Keren Bar-Hava (CPA) withdrew her candidacy for election as a director and has been appointed as an observer to the Board. The Group has also withdrawn its previously issued position statement. Each member of the Group publicly expressed full confidence in ZIM's Board of Directors, strongly supported the Board's ongoing strategic review, and endorsed the election of all ten director nominees recommended by the Board. Each member of the Group supported and was in favor of the Issuer's slate at the Annual Meeting and encouraged all ZIM shareholders to vote in favor of all the nominees.

On December 16, 2025, the Group reached an agreement with the Issuer regarding the composition of the Issuer's Board of Directors ahead of ZIM's upcoming Annual and Extraordinary General Meeting of Shareholders scheduled to be held on December 26, 2025 (the "Annual Meeting"). Pursuant to the agreement, the Group agreed to withdraw its proxy contest, and ZIM's Board of Directors has approved a unified slate of ten director nominees to be presented to the shareholders at the Annual Meeting. The slate includes each of the Issuer's incumbent directors, as well as Ron Hadassi and Ran Gritzerstein, who will be recommended by the Board for election. In addition, Dr. Keren Bar-Hava (CPA) withdrew her candidacy for election as a director and has been appointed as an observer to the Board. The Group has also withdrawn its previously issued position statement. Each member of the Group publicly expressed full confidence in ZIM's Board of Directors, strongly supported the Board's ongoing strategic review, and endorsed the election of all ten director nominees recommended by the Board. Each member of the Group supported and was in favor of the Issuer's slate at the Annual Meeting and encouraged all ZIM shareholders to vote in favor of all the nominees.

On December 16, 2025, the Group reached an agreement with the Issuer regarding the composition of the Issuer's Board of Directors ahead of ZIM's upcoming Annual and Extraordinary General Meeting of Shareholders scheduled to be held on December 26, 2025 (the "Annual Meeting"). Pursuant to the agreement, the Group agreed to withdraw its proxy contest, and ZIM's Board of Directors has approved a unified slate of ten director nominees to be presented to the shareholders at the Annual Meeting. The slate includes each of the Issuer's incumbent directors, as well as Ron Hadassi and Ran Gritzerstein, who will be recommended by the Board for election. In addition, Dr. Keren Bar-Hava (CPA) withdrew her candidacy for election as a director and has been appointed as an observer to the Board. The Group has also withdrawn its previously issued position statement. Each member of the Group publicly expressed full confidence in ZIM's Board of Directors, strongly supported the Board's ongoing strategic review, and endorsed the election of all ten director nominees recommended by the Board. Each member of the Group supported and was in favor of the Issuer's slate at the Annual Meeting and encouraged all ZIM shareholders to vote in favor of all the nominees.

On December 16, 2025, the Group reached an agreement with the Issuer regarding the composition of the Issuer's Board of Directors ahead of ZIM's upcoming Annual and Extraordinary General Meeting of Shareholders scheduled to be held on December 26, 2025 (the "Annual Meeting"). Pursuant to the agreement, the Group agreed to withdraw its proxy contest, and ZIM's Board of Directors has approved a unified slate of ten director nominees to be presented to the shareholders at the Annual Meeting. The slate includes each of the Issuer's incumbent directors, as well as Ron Hadassi and Ran Gritzerstein, who will be recommended by the Board for election. In addition, Dr. Keren Bar-Hava (CPA) withdrew her candidacy for election as a director and has been appointed as an observer to the Board. The Group has also withdrawn its previously issued position statement. Each member of the Group publicly expressed full confidence in ZIM's Board of Directors, strongly supported the Board's ongoing strategic review, and endorsed the election of all ten director nominees recommended by the Board. Each member of the Group supported and was in favor of the Issuer's slate at the Annual Meeting and encouraged all ZIM shareholders to vote in favor of all the nominees.

On December 16, 2025, the Group reached an agreement with the Issuer regarding the composition of the Issuer's Board of Directors ahead of ZIM's upcoming Annual and Extraordinary General Meeting of Shareholders scheduled to be held on December 26, 2025 (the "Annual Meeting"). Pursuant to the agreement, the Group agreed to withdraw its proxy contest, and ZIM's Board of Directors has approved a unified slate of ten director nominees to be presented to the shareholders at the Annual Meeting. The slate includes each of the Issuer's incumbent directors, as well as Ron Hadassi and Ran Gritzerstein, who will be recommended by the Board for election. In addition, Dr. Keren Bar-Hava (CPA) withdrew her candidacy for election as a director and has been appointed as an observer to the Board. The Group has also withdrawn its previously issued position statement. Each member of the Group publicly expressed full confidence in ZIM's Board of Directors, strongly supported the Board's ongoing strategic review, and endorsed the election of all ten director nominees recommended by the Board. Each member of the Group supported and was in favor of the Issuer's slate at the Annual Meeting and encouraged all ZIM shareholders to vote in favor of all the nominees.

On December 16, 2025, the Group reached an agreement with the Issuer regarding the composition of the Issuer's Board of Directors ahead of ZIM's upcoming Annual and Extraordinary General Meeting of Shareholders scheduled to be held on December 26, 2025 (the "Annual Meeting"). Pursuant to the agreement, the Group agreed to withdraw its proxy contest, and ZIM's Board of Directors has approved a unified slate of ten director nominees to be presented to the shareholders at the Annual Meeting. The slate includes each of the Issuer's incumbent directors, as well as Ron Hadassi and Ran Gritzerstein, who will be recommended by the Board for election. In addition, Dr. Keren Bar-Hava (CPA) withdrew her candidacy for election as a director and has been appointed as an observer to the Board. The Group has also withdrawn its previously issued position statement. Each member of the Group publicly expressed full confidence in ZIM's Board of Directors, strongly supported the Board's ongoing strategic review, and endorsed the election of all ten director nominees recommended by the Board. Each member of the Group supported and was in favor of the Issuer's slate at the Annual Meeting and encouraged all ZIM shareholders to vote in favor of all the nominees.

On December 16, 2025, the Group reached an agreement with the Issuer regarding the composition of the Issuer's Board of Directors ahead of ZIM's upcoming Annual and Extraordinary General Meeting of Shareholders scheduled to be held on December 26, 2025 (the "Annual Meeting"). Pursuant to the agreement, the Group agreed to withdraw its proxy contest, and ZIM's Board of Directors has approved a unified slate of ten director nominees to be presented to the shareholders at the Annual Meeting. The slate includes each of the Issuer's incumbent directors, as well as Ron Hadassi and Ran Gritzerstein, who will be recommended by the Board for election. In addition, Dr. Keren Bar-Hava (CPA) withdrew her candidacy for election as a director and has been appointed as an observer to the Board. The Group has also withdrawn its previously issued position statement. Each member of the Group publicly expressed full confidence in ZIM's Board of Directors, strongly supported the Board's ongoing strategic review, and endorsed the election of all ten director nominees recommended by the Board. Each member of the Group supported and was in favor of the Issuer's slate at the Annual Meeting and encouraged all ZIM shareholders to vote in favor of all the nominees.

On December 16, 2025, the Group reached an agreement with the Issuer regarding the composition of the Issuer's Board of Directors ahead of ZIM's upcoming Annual and Extraordinary General Meeting of Shareholders scheduled to be held on December 26, 2025 (the "Annual Meeting"). Pursuant to the agreement, the Group agreed to withdraw its proxy contest, and ZIM's Board of Directors has approved a unified slate of ten director nominees to be presented to the shareholders at the Annual Meeting. The slate includes each of the Issuer's incumbent directors, as well as Ron Hadassi and Ran Gritzerstein, who will be recommended by the Board for election. In addition, Dr. Keren Bar-Hava (CPA) withdrew her candidacy for election as a director and has been appointed as an observer to the Board. The Group has also withdrawn its previously issued position statement. Each member of the Group publicly expressed full confidence in ZIM's Board of Directors, strongly supported the Board's ongoing strategic review, and endorsed the election of all ten director nominees recommended by the Board. Each member of the Group supported and was in favor of the Issuer's slate at the Annual Meeting and encouraged all ZIM shareholders to vote in favor of all the nominees.